View Post

Seattle lab’s vaccine could be cancer breakthrough

In In The News by Barbara Jacoby

By: John Knicely From: myajc.com Etubics Corporation, a biopharmaceutical company in Seattle’s Lower Queen Anne neighborhood, is moving forward after a major breakthrough in treating cancer patients. A new type of treatment more than doubled the life span of some cancer patients. Now, the lab has the backing of the National Cancer Institute in testing its immunotherapy for cancer patients. …

View Post

New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients across the United States

In In The News by Barbara Jacoby

The Guardian Research Network and Molecular Health will Provide Cancer Patients with Personalized Clinical Decision Support Cambridge, MA / Spartanburg, SC – The Guardian Research Network and Molecular Health have announced collaboration designed to provide therapeutic clinical trial access and molecular diagnostic decision support to the majority of cancer patients living in U.S. communities. The Guardian Research Network will collaborate …

View Post

Cancer immunotherapy takes aim at mutation-riddled tumors

In In The News by Barbara Jacoby

By: Jocelyn Kaiser From: sciencemag.org New immune system-boosting cancer drugs have in clinical trials saved the lives of many people with seemingly untreatable melanoma or lung cancer, but the drugs seem useless against colon cancer. One exception—a man with colon cancer whose metastatic tumors vanished for several years after he was treated in 2007—piqued researchers’ interest. They suspected his recovery …

View Post

Novartis announces two positive US phase III programs in COPD for QVA149 and NVA237

In In The News by Barbara Jacoby

 From: yahoo.com QVA149 improved lung function, breathlessness and health-related quality of life in moderate-to-severe COPD patients, according to EXPEDITION trial results[1]-[7] GEM 1 & 2 studies showed NVA237 provided significant and clinically meaningful improvements in lung function in moderate-to-severe COPD patients[8],[9] In total, 26 Novartis abstracts presented at American Thoracic Society (ATS) 2015; showcasing breadth of respiratory portfolio Basel, May …

View Post

Can the Polio Virus Cure Cancer?

In In The News by Barbara Jacoby

By: Nick Tate From: newsmax.com An experimental program at Duke University is using a surprising new weapon in the war on cancer — infusions of the polio virus that have successfully been used to treat patients with inoperable brain tumors. While the doctors and researchers spearheading the effort are reluctant to use the words “cancer cure” to describe the work, …

View Post

Bladder Cancer Breakthrough Treatment Developed after 30 Years

In In The News by Barbara Jacoby

A much-awaited breakthrough in the treatment for advanced bladder cancer has been made by scientists from the Barts Cancer Institute of Queen Mary University of London. The breakthrough, which is the first major advancement in the treatment of the dreaded disease over the past 30 years, is detailed in a paper published in the Nature journal. The research studied MPDL3280A, an …

Austin company may help cure common cancer side effect

In In The News by Barbara Jacoby

Bt: Terri Gruca, KVUE From: khou.com As part of Breast Cancer Awareness Month, KVUE wants to bring you stories that put faces to all the pink that you see. More than that, we want to share some of the amazing scientific breakthroughs happening in our own backyard including a new treatment that could help breast cancer survivors deal with one …

Scorpion venom leads local doctors to cancer breakthrough

In In The News by Barbara Jacoby

By: Matt Markovich From: komonews.com Seattle-based Blaze Bioscience recently crossed an important milestone when it got the go ahead to begin clinical trials on humans for its tumor paint. The FDA gave its blessing to inject 21 brain cancer patients with the cancer detecting compound made from the venom of deathstalker scorpions. Tumor paint allows surgeons to spot cancerous tissue …

Breaking News…The Pink Vaccine is Coming! Clinical Trials to begin in 2015

In In The News by Barbara Jacoby

For the past eleven years there has been a dream in the making; a world without breast cancer. This dream was based on a vision to eradicate the disease using a revolutionary approach; that of immune prevention.  Breast cancer immunoprevention was and continues to be the mission of Dr. Vincent K. Tuohy and his team at the Learner Research Institute …